Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
40%(2 trials)
Terminated
1(14%)

Phase Distribution

Ph not_applicable
1
14%
Ph phase_3
1
14%
Ph phase_4
3
43%
Ph phase_2
1
14%
Ph phase_1
1
14%

Phase Distribution

1

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
3(42.9%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(5)
Terminated(2)

Detailed Status

Completed5
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (14.3%)
Phase 21 (14.3%)
Phase 31 (14.3%)
Phase 43 (42.9%)
N/A1 (14.3%)

Trials by Status

completed571%
withdrawn114%
terminated114%

Recent Activity

0 active trials
Showing 5 of 7
terminatedphase_3

Bismuth Subsalicylate's Role in the Prevention of Travelers' Diarrhea

NCT03535272
completedphase_1

Effect of Bismuth Subsalicylate on the Gut Microbiome and Host Response in Healthy Adults

NCT05930197
completedphase_4

THE EFFECT OF HELICOBACTER PYLORI ERADICATION THERAPY TO GASTRIC WALL THICKNESS BEFORE THE LAPAROSCOPIC SLEEVE GASTRECTOMY

NCT03757650
completednot_applicable

Impact of Bismuth Subsalicylate on Antimicrobial Use Among Adult Diarrhea Outpatients--Pakistan

NCT02047162
completedphase_2

Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach

NCT00002682
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT03535272Phase 3

Bismuth Subsalicylate's Role in the Prevention of Travelers' Diarrhea

Terminated
NCT05930197Phase 1

Effect of Bismuth Subsalicylate on the Gut Microbiome and Host Response in Healthy Adults

Completed
NCT03757650Phase 4

THE EFFECT OF HELICOBACTER PYLORI ERADICATION THERAPY TO GASTRIC WALL THICKNESS BEFORE THE LAPAROSCOPIC SLEEVE GASTRECTOMY

Completed
NCT02047162Not Applicable

Impact of Bismuth Subsalicylate on Antimicrobial Use Among Adult Diarrhea Outpatients--Pakistan

Completed
NCT00002682Phase 2

Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach

Completed
NCT03592082Phase 4

Use of Bismuth Subsalicylate in Clostridium Difficile Colitis

Withdrawn
NCT01742429Phase 4

Levofloxacin and Bismuth-containing Therapy Versus Quadruple Therapy as Second-line Treatment of Resistant Helicobacter Pylori Infection

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7